Consensus Epigenomics AG Xetra

Equities

ECX

DE000A3H2184

Delayed Xetra Other stock markets 10:06:16 23/12/2022 pm IST			5-day change	1st Jan Change
1.512 ^EUR	-0.26%		+0.27%	-41.03%

30/04	Epigenomics AG Announces Jens Ravens Leaves as Executive Board Member	CI
14/03	Epigenomics AG Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Evolution of the average Target Price on Epigenomics AG

Price target over the last 5 years

History of analyst recommendation changes

5c5ff6b69513f3c399454e.NR6lWhV9z0sjznKxcJseKqsOxdPk5XXf16ZyiLJEguc.eVr9ACIW-XJsiBnwNOEmUO9vh5KxghyHutYH-4Nx8qkBSJ0bWAX8IXCsMw~4062bfb82a7561092f1b3ba6eb219fac

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.7 EUR

Average target price

15.75 EUR

Spread / Average Target

+2,150.00%

High Price Target

15.75 EUR

Spread / Highest target

+2,150.00%

Low Price Target

15.75 EUR

Spread / Lowest Target

+2,150.00%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar